Ledger.Open graph →
SEC Form D · Amendment · filed August 14, 2014

EFFECTOR THERAPEUTICS, INC

Offering
$57.0M
Sold
$21.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Kriss E. Spradley · CHICAGO, ILExecErik S. Nelson · CHICAGO, ILDirectorStephen A. Zabawa · CHICAGO, ILDirectorRyan M. Gee · CHICAGO, ILDirectorStevan Rosenberg · Farmington Hills, MIExec · DirectorCarol G. Gallagher, Pharm.D · San Diego, CADirectorHenry C. Hansel · CHICAGO, ILExec · DirectorRaymond T. Kish · CHICAGO, ILExec · DirectorAndrew J. Bresolin · CHICAGO, ILDirectorAmanda J. Forbes · HAMILTON, BermudaDirectorJohn G. Neal · HAMILTON, BermudaDirectorThomas J. Bladek · Easton, CTDirectorWilliam J. Duggan · Glastonbury, CTDirectorChristopher A. Greenberg · Worthington, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗